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Abstract We examined the distributions of seven polymorphic sites 
in three apolipoprotein genes (APOE, APOA4, and APOH) and their 
relationships with quantitative lipid levels (total cholesterol, LDL cho-
lesterol, HDL cholesterol, and triglycerides) among the Evenki reindeer 
herders of central Siberia. The polymorphism data reveal several distinc-
tive features that differentiate the Evenki from white populations: the 
near absence of the APOE*2 allele, the highest ever recorded frequency 
of the APOH*3 allele, the complete absence of the APOA*2 allele at 
codon 360, and significantly different frequencies at three other APOA4 
polymorphic sites. Our analyses of the relationships of common apoli-
poprotein polymorphism and plasma lipid levels also revealed interesting 
results. The well-established positive association between the APOE*4 
allele and LDL cholesterol level reported in white populations was not 
seen in the Evenki despite a comparable frequency of the APOEH allele. 
Because the Evenki have significantly lower cholesterol levels than West-
ernized whites, this difference in allelic effect probably reflects gene-diet 
interaction, which modulates the effect of APOE polymorphism on LDL 
cholesterol. At the APOA4 locus the Hincll polymorphism at codon 127 
shows a significant impact on plasma triglyceride variation in the Evenki 
sample: The Hincll — allele was associated with higher triglyceride lev-
els than the Hincll + allele. Our data indicate that both the genetic and 
the environmental factors conventionally associated with cardiovascular 
disease risk in Western societies are different in the Evenki. 
Apolipoproteins (apo, protein; APO, gene) are the protein moieties of plasma 
lipoprotein particles that play an important role in the secretion, processing, 
and catabolism of lipoproteins. Genetic studies carried out mainly in Euro-
pean and American white populations show that common genetic variations 
in genes coding for apolipoproteins have a significant impact on interindivid-
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ual variation in plasma lipid levels and thus affect the risk for cardiovascular 
disease in the general population [reviewed by Sing and Moll (1990) and 
Chan and Dresel (1990)]. However, except for a few studies of Amerindians 
(Kamboh et al. 1991; Crews et al. 1993) and Eskimos (De Knijff et al. 1992), 
the distribution of common genetic variations in apolipoprotein genes and 
their relationships with plasma quantitative traits related to cardiovascular 
disease risk have not been systematically evaluated in the Arctic area. To fill 
this gap in this part of the world, we have studied seven polymorphic sites in 
three apolipoprotein genes (APOE, APOH, and APOA4) among the Evenki 
reindeer herders of central Siberia in Russia. 
APOE is the most studied polymorphic gene involved in lipoprotein 
metabolism (Davignon et al. 1988). It is a ligand for two cell-surface recep-
tors—low-density lipoprotein (LDL) receptor and LDL-related protein recep-
tor (LRP)—and mediates the uptake of apoE-containing lipoprotein particles 
by cells. Three common APOE alleles, APOE*2, APOE*3, and APOEH, 
play a significant role in affecting normal plasma cholesterol variation in 
populations with diverse ethnic backgrounds (Hallman et al. 1991). 
Although the precise function of apoA4 is uncertain, it is thought to 
play an important role in the metabolism of high-density lipoprotein (HDL) 
and triglyceride-rich lipoprotein particles (Steinmetz et al. 1990; Goldberg et 
al. 1990). Several polymorphisms in the APOA4 gene have been reported, 
and some of them have a significant impact on plasma lipid variation (von 
Eckardstein et al. 1992). 
APOH is believed to be involved in triglyceride metabolism, but its 
precise role is still unknown. The APOH gene exhibits a common polymor-
phism with the occurrence of three alleles. The effect of APOH polymorphism 
on plasma lipid levels has yet to be determined unequivocally (Kamboh and 
Ferrell 1991). 
In this article we report the distribution of selected apolipoprotein poly-
morphisms and their role in determining interindividual variation in total cho-
lesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels among the 
Evenki people of Siberia. 
Materials and Methods 
The Population. This study was conducted on plasma and DNA samples 
collected from the Evenki, who have settled in the Tunguska region of central 
Siberia. Most of the blood samples were collected from fasting individuals, 
and the results of lipid quantitation, including total, LDL, and HDL choles-
terol and triglyceride levels, have been described by Leonard, Crawford et al. 
(1994). 
The Evenki are a Tungusic-speaking group whose settlements are dis-
tributed over the boreal forest (taiga) region of central Siberia in Russia. The 
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Table 1. Primer Sequences and Expected Fragment and Restriction Enzyme Sizes for 
APOE and APOA4 Polymorphisms 
Polymorphic Restriction Fragment 
Gene Site Enzyme Primer Size (bp) 
APOEa codons 112 Hhal 5 '-GCGGACATGGAGGACGTG-3' 111 
and 158 5' -GGCCTGGTACACTGCC AG-3' 
APOA4b codon 127 Hincll 5' -GCTGCTGCCCC ATGCC AATG-3' 192 
codon 130 Hae III 5 '-TGC AGGCTGTCGGCGTTCTC-3' 
APOA40 codon 347 Hinfl 5 '-CGGGTGGAGCCCTACGGGGA-3' 300 
codon 360 Fnumi 5' -TGGGGCC AGTGC ACC AGGGG-37 
APOA4b exon 3 VNTR 5AGATGCTGGCCCCTTTGGAG-3' 187/191 
(noncoding 5 '-GAGGCTAGATTCTCAGCAGC-3' 
region) 
a. Kamboh, Aston et al. (1995). 
b. This study. 
c. Kamboh et al. (1992). 
Evenki show reduced growth in stature and body weight compared with the 
American white normative data (Leonard, Katzmarzyk et al. 1994). Although 
the Evenki derive a large portion of their diet from reindeer meat and milk, 
they do not have a high fat intake. 
The traditional Evenki also have high levels of energy expenditure, and 
this is reflected in their low serum lipid levels (Leonard, Crawford et al. 1994). 
Mean total cholesterol (men, 137 ± 2.8 mg/dl; women, 140 ± 4.5 mg/dl), 
LDL cholesterol (men, 72 ± 2.5 mg/dl; women, 78 ± 3.4 mg/dl), and tri-
glyceride (men, 87 ± 3.7 mg/dl; women, 83 ± 5.2 mg/dl) levels in the 
Evenki are significantly lower compared with American whites (Johnson et 
al. 1993). However, the mean HDL cholesterol level in the Evenki (men, 47 
± 1.3 mg/dl; women, 46 ± 1.9 mg/dl) is comparable to that seen in American 
whites. 
Apolipoprotein Genotyping. With the exception of the APOH polymor-
phism, which was evaluated by isoelectric focusing and immunoblotting tech-
niques in plasma (Kamboh et al. 1988), all other polymorphisms in the APOE 
and APOA4 genes were screened using specific polymerase chain reaction 
(PCR) protocols. The primer sequences, expected fragment sizes, and restric-
tion enzymes used to analyze the APOE and APOA4 polymorphisms are 
given in Table 1. 
Statistical Analysis. Allele frequencies were estimated by allele counting. 
Hardy-Weinberg equilibrium was tested by a chi-square goodness-of-fit test. 
To evaluate the effect of each polymorphism on the variation of quantitative 
variables of lipid and apolipoprotein, we carried out an analysis of covariance 
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(ANCOVA). The distributions of all the variables were tested for normality. 
The effects of covariates (age and body mass index) were determined by 
stepwise regression. Body mass index (BMI) was computed as weight in 
kilograms divided by height in meters squared. All statistical analyses were 
done using the statistical software package SAS. 
Quantitative values more than three standard deviations from the mean 
were excluded as outliers from further analyses. This excluded at most two 
individuals from the analysis of any one quantitative trait except for HDL 
cholesterol level in males, where four individuals were excluded. Only the 
two common APOE genotypes, APOE*3/*3 and APOE*3l*4, were included 
to estimate the impact of APOE polymorphism on quantitative traits. The 
number of observations in each of the two remaining classes, APOE*2l*4 
and APOEHIH, were insufficient to be included in the statistical analyses. 
Similarly, only the APOH genotypes AP0#*2/*2 and AP6>#*2/*3, the 
APOA4/tfmcII genotypes + + and + - , and the APOA4/VNTR genotypes 
ID and II were included in the analyses. 
Analysis of variance was performed separately for males and females 
and for the sexes combined, with sex as a potential covariate, to test the null 
hypothesis of equality of means of quantitative traits between apolipoprotein 
genotypes. Initially, for the combined sexes all dependent quantitative vari-
ables except for total and LDL cholesterol levels were normalized by taking 
natural logarithms to ensure that the distribution of the dependent variable 
was Gaussian. For the analysis of the sexes separately, only triglyceride level 
required a ln-transformation for both sexes, whereas HDL cholesterol level 
required a ln-transformation only in females. 
Significant covariates for each dependent variable were identified using 
stepwise regression, with an overall 5% level of significance used to select 
the most parsimonious set of covariates for each dependent variable. The 
covariates considered were the linear effects of age, height, weight, and BMI. 
Each dependent quantitative variable was then adjusted to remove the effects 
of their respective set of significant covariates. The average excess for each 
allele was estimated according to the method of Templeton (1987) with some 
modifications (Kamboh, Aston et al. 1995). 
The contribution of the apolipoprotein gene to variation in the depen-
dent quantitative traits was estimated according to the method of Boerwinkle 
and Sing (1986). The proportion of the total phenotypic variability attributable 
to the apolipoprotein polymorphism was estimated by s2G/(s2G + si), where 
sw is the phenotypic variance among individuals with the same genotype. 
Results 
Genotype Distributions and Allele Frequencies. Of the six expected 
APOE genotypes resulting from three alleles, only four were observed 
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Table 2. Distributions of A P O E Genotype and Allele Frequencies in the Evenki 
APOE Genotype or Allele Number (%) Frequency 
Genotype 
*3/*3 90 (72.6) 
*3/*4 29 (23.4) 
*4/*4 4 (3.2) 






(Table 2). The two common genotypes, APOE*3/*3 and APOE*3M} con-
stituted 96% of the total distribution. Only one example of the APOE*2 allele 
was observed, giving an estimated allele frequency of 0.004, which is well 
below the average frequency of 0.08 seen in American and European white 
populations (Kamboh and Ferrell 1990). However, the frequency of the 
APOE*4 allele was comparable to that reported in whites. 
The two most common APOH genotypes were APOH*2/*2 (62.8%) 
and APOH*2l*3 (30.1%) (Table 3). The APOH*l allele was observed spo-
radically in combination with the two common alleles. Compared with Amer-
ican and European white populations, the Evenki have a significantly lower 
frequency of the APOH*l allele (0.01 vs. 0.06; p < 0.001) and a higher 
frequency of the APOH*3 allele (0.20 vs. 0.06; p < 0.0001). We further 
subtyped the APOH*3 allele based on its reactivity with an apoH monoclonal 
antibody, 3D 11 (Kamboh, Wagenknecht et al. 1995). Thirty-seven of 40 
Table 3. Distribution of APOH Genotype and Allele Frequencies in the Evenki 
APOH Genotype or Allele Number (%) Frequency 
Genotype 
*2/*2 71 (62.8) 
*2/*J 34 (30.1) 
*3/*3 5 (4.4) 
*l/*2 2(1.8) 
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Table 4. Distributions of Genotype and Allele Frequencies at Five Sites in the AP0A4 
Gene in the Evenki 
Polymorphic Site Genotype (%) Allele Frequency 
Codon 127 (Hincll) 
+ + = 60 (44.4) + = 0.707 
+ - = 71 (52.6) - = 0.293 
— 4 (3.0) 
Total = 135 
+ + = 132 (98.5) + = 0.993 
+ - = 2(1.5) -=0 .007 
Total = 134 
A4 = 122 (96.8) A = 0.984 
AT = 4 (3.2) T = 0.016 
Total = 126 
1 - 1 - 1 3 1 1 = 1.00 
DD — 1 (5.4) D = 0.289 
ID = 61 (46.9) 1 = 0.711 
II = 62 (47.7) 
Total = 130 
Codon 130 (HaeIII) 
Codon 347 (Hinfl) 
Codon 360 (FnuAHl) 
VNTR (exon 3) 
(92.5%) Evenki with the APOH*3 allele were found to be of the APOH*? 
subtype, a frequency similar to that found in American whites. 
Table 4 shows APOA4 genotype and allele frequency data at five poly-
morphic sites, including codons 127, 130, 347, and 360 and the 3' noncoding 
region in exon 3. With the exception of codon 360, all sites were polymorphic 
in the Evenki. At codon 127 the frequency of the Hincll - allele was sig-
nificantly higher in the Evenki than in European whites (0.29 vs. 0.21; p < 
0.05) (Tenkanen et al. 1992). At codon 130 only two individuals with the 
variant allele (HaeIII - ) were observed in the Evenki sample compared with 
its polymorphic occurrence (allele frequency 0.04) in American whites (Kam-
boh, unpublished data, 1994). Compared with American and European 
whites, where there is a common polymorphism at codon 347 (Kamboh et 
al. 1992; Tenkanen et al. 1992), the Evenki are less variable at this site (0.19 
vs. 0.02 allele frequency of the Hinfl T allele). In the noncoding region of 
exon 3 there is a VNTR (variable number of tandem repeats) polymorphism 
with either three (deletion) or four (insertion) tetranucleotide repeats (CTGT) 
with respective allele frequencies of 0.61 and 0.39 in European whites (von 
Eckardstein et al. 1992). Interestingly, the pattern of this distribution was 
reversed in the Evenki sample with the common occurrence of the 4-base 
insertion allele (see Table 4). 
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Table 5. Mean Adjusted Values of Plasma Lipid Levels ( ± Standard Error) among Two 
Common APOE Genotypes in the Evenki 
Men Women Combined 
Lipid *3/*3 *3/*4 *3/*3 *3/*4 *3/*3 *3/*4 
Variable (n = 55) (n = 18) p (n = 31) (n = 11) p (n = 86) (n = 29) p 
Total 
cholesterol 
(mg/dl) 134.9 ± 3.1 142.0 ± 5.6 0.24 142.6 ± 6.6 129.9 ± 10.9 0.12 137.6 ± 3.0 137.7 ± 5.2 0.75 
LDL 
cholesterol 
(mg/dl) 70.2 ± 2.8 80.2 ± 5.1 0.1 l a 82.4 ± 6.4 65.6 ± 10.7 0.07b 75.0 ± 2.8 74.3 ± 4.9 0.69 
HDL 
cholesterol 
(mg/dl) 44.6 ± 1.1 47.8 ± 1.8 0.12 45.8 ± 2.0 44.7 ± 3.4 0.78 45.0 ± 1.0 46.7 ± 1.7 0.40 
Triglycerides 
(mg/dl) 78.9 ± 3.8 88.2 ± 7.7 0.27 75.5 ± 5.6 69.7 ± 8.5 0.57 78.1 ± 3.3 79.3 ± 5.9 0.99 
a. R2 X 100 = 3.4. 
b. R2 X 100 = 7.9. 
Genotype Effects on Lipid Levels. Table 5 shows genotype specific 
means of four lipid traits among the two most common APOE genotypes 
(APOE*3/*3 and APOE*3l*4). No significant variability among the two 
APOE genotypes was observed for any trait. However, a borderline effect (p 
— 0.07) on LDL cholesterol level was noted among women, where the 
APOE*3l*4 genotype was associated with lower LDL cholesterol levels com-
pared with the APOE*3l*3 genotype. The APOE polymorphism explained 
8% of the phenotypic variance in LDL cholesterol level in women. 
Mean adjusted values of plasma lipid levels among the two common 
APOH genotypes (APOH*2/*2 and APOH*2/*3) are shown in Table 6. Com-
pared to the APOH*2/*2 genotype, the APOH*2l*3 genotype is associated 
with lower triglyceride levels in men and higher triglyceride levels in women, 
but in both cases the difference is not statistically significant. All other lipid 
traits showed comparable values between the two APOH genotypes. 
Tables 7 and 8 present the distributions of mean lipid levels among 
common genotypes of the APOA4/#/wcII and VNTR polymorphisms, re-
spectively. Although the VNTR polymorphism showed no effect on any lipid 
trait, the Hincll polymorphism at codon 127 showed a significant effect on 
plasma triglyceride level. Individuals with the Hincll + + genotype had a 
significantly lower triglyceride level compared with the Hincll + - genotype 
(p = 0.01). Although this directional trend was seen in both sexes, it was 
statistically significant only in women (p = 0.009), where this polymorphism 
explained 15.2% of the phenotypic variance in triglyceride level. 
Because of small sample sizes of the less common genotypes in other 
APOA4 polymorphisms (codons 130 and 347), these samples were not ana-
lyzed with respect to plasma lipid levels. 
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Table 6. Mean Adjusted Values of Plasma Lipid Levels ( ± Standard Error) among Two 
Common APOH Genotypes in the Evenki 
Men Women Combined 
Lipid *2/*2 *2/*3 *2/*2 *2/*3 *2/*2 *2/*3 
Variable (n = 40) (n = 24) p (n = 25) (n = 9) p (n = 65) (n = 33) p 
Total 
cholesterol 
(mg/dl) 134.7 ± 3.5 138.9 ± 4.5 0.49 140.6 ± 5.3 140.1 ± 8.8 0.88 136.8 ± 2.9 139.8 ± 4.1 0.62 
LDL 
cholesterol 
(mg/dl) 71.7 ± 3.2 77.0 ± 4.2 0.36 82.9 ± 4.6 75.9 ± 7.7 0.44 76.0 ± 2.8 77.9 ± 4.0 0.70 
HDL 
cholesterol 
(mg/dl) 45.2 ± 1.2 44.6 ± 1.5 0.76 45.1 ± 2.2 45.4 ± 3.7 0.94 45.1 ± 1.1 44.8 ± 1.5 0.86 
Triglycerides 
(mg/dl) 86.6 ± 4.8 74.9 ± 5.4 0.12a 69.4 ± 5.2 86.9 ± 10.9 0.13 b 79.5 ± 3.6 78.0 ± 5.1 0.79 
a. J"?2 X 100 = 3.8. 
b. .K2 X 100 = 6.7. 
Discussion 
We examined the distribution patterns of seven polymorphic sites in 
three apolipoprotein genes and their relationships with plasma lipid levels in 
the Evenki reindeer herders of central Siberia. The gene frequency data reveal 
several interesting features that differentiate the Evenki from American and 
European white populations. These distinctive features among the Evenki are 
Table 7. Mean Adjusted Values of Plasma Lipid Levels ( ± Standard Error) among Two 
Common Hincll Genotypes at Codon 127 in the APOA4 Gene in the Evenki 
Men Women Combined 
Lipid + + +- + + + + + -
Variable (n = 32) (n = 47) p (n = 20) (n = 22) p (n = 52) in = 69) p 
Total 
cholesterol 
(mg/dl) 136.5 ± 4.1 136.6 ± 3.4 0.96 138.6 ± 8.0 140.5 ± 7.7 0.37 137.3 ± 3.7 137.9 ± 3.3 0.57 
LDL 
cholesterol 
(mg/dl) 73.0 ± 3 . 8 71.3 ± 3.2 0.59 82.8 ± 7.8 75.4 ± 7.8 0 86 77.5 ± 3.5 72.4 ± 3.1 0.51 
HDL 
cholesterol 
(mg/dl) 44.1 ± 1.4 46.8 ± 1.1 0.14 45.1 ± 2.6 44.2 ± 2.6 0.81 44.5 ± 1.3 46.0 ± 1.1 0.40 
Triglycerides 
(mg/dl) 76.9 ± 4.9 82.9 ± 4.4 0.37 64.0 ± 5.2 86.9 ± 6.7 0.0093 72.1 ± 3.7 83.8 ± 3.8 0.01b 
a. R2 X 100 = 15.2. 
b. R2 X 100 = 4.9. 
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Table 8. Mean Adjusted Lipid Levels ( ± Standard Error) among Two Common Gen-
otypes of a VNTR Polymorphism in the Noncoding Region of Exon 3 in the APOA4 Gene 
in the Evenki 
Men Women Combined 
Upid ID II ID II n 
Variable (n = 32) (n = 38) p (n = 18) (n = 22) p (n = 50) (n = 60) p 
Total 
cholesterol 
(mg/dl) 132.8 ± 4.1 138.8 ± 3.7 0.31 134.9 ± 8.8 144.8 ± 8.2 0.96 133.9 ± 3.9 140.8 ± 3.6 0.51 
LDL 
cholesterol 
(mg/dl) 69.1 ± 4.0 75.2 ± 3.6 0.35 72.2 ± 8.8 85.3 ± 8.0 0.88 71.2 ± 3.7 78.0 ± 3.4 0.43 
HDL 
cholesterol 
(mg/dl) 44.8 ± 1.4 45.6 ± 1.3 0.67 42.6 ± 2.8 45.8 ± 2.5 0.40 44.0 ± 1.4 45.7 ± 1.2 0.36 
Triglycerides 
(mg/dl) 81.2 ± 4.9 79.8 ± 4.4 0.83 73.1 ± 6.7 81.9 ± 6.6 0.36 78.4 ± 4.3 80.4 ± 3.8 0.91 
(1) the near absence of the APOE*2 allele, (2) the highest ever recorded 
frequency of the APOH*3 allele, (3) the sporadic detection of the variant 
alleles at codons 130 and 347 in the APOA4 gene, (4) the complete absence 
of the APOA4*2 allele at codon 360, (5) significantly higher frequencies of 
the APOA4 Hincll - allele at codon 127, and (6) a significantly lower fre-
quency of the APOA4 deletion allele in the VNTR region. 
The complete absence of the APOA4*2 allele, which is a unique marker 
of white populations, provides further evidence that the Evenki are genetically 
isolated from other population groups of Russia. The near complete absence 
of the APOA4*2 allele in aboriginal populations of America has been noted 
previously (Kamboh et al. 1991; De Knijff et al. 1992). A relatively high 
frequency of the APOH*3, APOA4 Hincll and APOA4 insertion alleles 
in the Evenki may have been attained through genetic drift. 
Our analyses of the relationships between common genetic apolipopro-
tein polymorphisms and plasma lipid traits among the Evenki revealed inter-
esting results. The well-established association between the APOE*4 allele 
and elevated plasma cholesterol levels in several white populations was not 
observed in the Evenki, despite their having a comparable frequency of the 
APOE*4 allele. In fact, among Evenki women the APOEH allele was asso-
ciated with a significantly lower LDL cholesterol level compared with the 
APOE*3 allele. The apparent absence of the positive association of the 
APOEH allele in this study may be due to significantly lower plasma cho-
lesterol levels in the Evenki compared with American and European whites. 
The estimation of allele effects on lipid levels involves both the fre-
quency of each allele in the sample and the grand mean and genotype-specific 
means of the quantitative variables. In this case, although the frequency of 
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the APOEH allele was comparable with that in whites, the population mean 
of plasma cholesterol levels was markedly lower in the Evenki than in those 
populations in which the effect of the APOEH allele was detected. Alterna-
tively, a specific gene-gene interaction or a unique pattern of linkage disequi-
librium present in the Evenki might have confounded the estimation of the 
allelic effect. 
However, the most plausible explanation of this different allelic effect 
between the Evenki and whites is a gene-diet interaction that modulates the 
effect of the APOE polymorphism. Despite consuming a diet that contains a 
large amount of animal meat, the Evenki do not have a high saturated fat 
intake, which contrasts with industrialized Western countries (Leonard, Craw-
ford et al. 1994). In addition to low fat intake, the Evenki also have high 
levels of energy expenditure (Leonard, Katzmarzyk et al. 1994), which ex-
plains why they have low cholesterol levels despite having a similar frequency 
of the atherogenic APOEH allele. 
Although the APOE polymorphism has been found to influence normal 
plasma cholesterol variation in populations with diverse ethnic backgrounds, 
exceptions have been noted in Malays from Singapore (Utermann 1987), 
Mayan Indians from Mexico (Kamboh et al. 1991), and Eskimos from Green-
land (De Knijff et al. 1992), further confirming that gene-environment (diet) 
interaction plays an important role in determining plasma lipid levels. 
Although the APOH polymorphism did not reveal a significant impact 
on any lipid traits, a gender-specific effect on triglyceride level was suggested, 
Among men the APOH*3 allele was associated with a lower triglyceride level 
compared with the common APOH*2 allele. However, in women the effecl 
of the APOH*3 allele was in the opposite direction. The elevating effect ol 
the APOH*3 allele on triglyceride level in women also has been described in 
an African sample (Sepehrnia et al. 1989). However, this effect of the 
APOH*3 allele has not been found to be consistent between studies (Eichnei 
et al. 1989; Kaprio et al. 1991; Saha et al. 1993; Cassader et al. 1994) and 
therefore may be a chance observation in this study. 
Among the five APOA4 polymorphisms studied only two (Hincll and 
VNTR) were polymorphic enough to be studied in relation to lipid levels. 
Similar to a previous report in European whites (von Eckardstein et al. 1992). 
the VNTR polymorphism in the Evenki was not associated with quantitative 
variation in lipid levels. However, the Hincll polymorphism at codon 127 
was found to have a significant impact on triglyceride variation (p = 0.01). 
Both men and women with the Hincll - allele had higher triglyceride levels, 
but the effect was more pronounced in women, where this polymorphism 
explained about 15% of the variation in triglyceride level. The absence oi 
the Hincll site at codon 127 is associated with the replacement of the com-
monly occurring asparagine by serine, and therefore this alternation in the 
primary structure of the apoA4 protein may have a direct impact on triglyc-
eride metabolism. Although the precise function of apoA4 in lipid metabolism 
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is uncertain, it appears to be involved in the metabolism of HDL and 
triglyceride-rich lipoprotein particles. ApoA4 enhances lipoprotein lipase 
(LPL) activity in the presence of apoC2, which is an essential cofactor for 
LPL activity (Goldberg et al. 1990). (LPL is an enzyme required for hydroly-
sis of core triglycerides of triglyceride-rich lipoprotein particles.) ApoA4 is 
thought to be required for the efficient release of apoC2 from HDL to 
triglyceride-rich lipoprotein particles, and therefore structural changes in the 
apoA4 molecule may play an important role in regulating the postprandial 
metabolism of lipoproteins. In this case the Hincll - allele (serine) may be 
less effective in transferring apoC2 from HDL compared with the Hincll + 
allele (asparagine), thus affecting LPL activity, which results in a high plasma 
triglyceride level in individuals carrying the Hincll - allele. It is noteworthy 
that not all samples collected in this investigation were taken from fasting 
subjects, and this may have helped to detect the effect of this polymorphism 
on triglyceride variation, which otherwise could have been obscured in non-
fasting subjects. 
In summary, this is the first study among the Evenki that investigated 
the extent of distributions of apolipoprotein gene polymorphisms and their 
impact on plasma quantitative risk factors for cardiovascular disease. We 
conclude that both the genetic and the environmental factors conventionally 
associated with cardiovascular disease risk in Western societies differ in the 
Evenki. 
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